← Leaderboards
Bin Gao
Virginia Commonwealth University
$700,617
Attributed
$1,903,830
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $380.7K · FY2019–23$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,903,830 · 2
By mechanism
U01$1,804,820 · 1
R29$99,010 · 1
Top collaborators
- Suthat Liangpunsakul5 shared
- Shelly Chi-Loo Lu5 shared
Others in their field
Top investigators on “Liver”
- David Heimbrook · Leidos Biomedical Research, Inc.$183,557,534
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Richard Douglas Moore · Johns Hopkins University$59,048,354
- Paul M. Ridker · Brigham And Women'S Hospital$55,416,022
- Michael S. Saag · University Of Alabama At Birmingham$50,288,385
- Mark A Kay · Stanford University$49,905,067
Research focus
LiverLaboratoriesPathogenesisHepaticCytokineCellsLiver DiseasesPlayInflammationFibrosisGenesNeutrophilAlcoholic Liver DiseasesImmuneInjuryChronicHepatocyteIn VitroMediatingAcuteEthanolSerumLiver InjuryMacrophage
Grant awards (58)
Pathogenesis and Novel Therapeutic Targets of Steatotic Liver Disease and Cancer$2,942,382
ZIA · FY2025 · AA · contact PI
Pathogenesis and Novel Therapeutic Targets of Fatty Liver Disease and Cancer$2,809,173
ZIA · FY2024 · AA · contact PI
Molecular mechanisms of liver injury, repair, and immunity$1,367,062
ZIA · FY2023 · AA · contact PI
Pathogenesis and Novel Therapeutic Targets of Fatty Liver Disease and Cancer$1,367,061
ZIA · FY2023 · AA · contact PI
S-adenosylmethionine treatment in alcoholic cirrhosis$352,736
U01 · FY2023 · AA
Pathogenesis and Novel Therapeutic Targets of Fatty Liver Disease and Cancer$1,313,141
ZIA · FY2022 · AA · contact PI
Molecular mechanisms of liver injury, repair, and immunity$1,313,140
ZIA · FY2022 · AA · contact PI
S-adenosylmethionine treatment in alcoholic cirrhosis$352,779
U01 · FY2022 · AA
Pathogenesis and Novel Therapeutic Targets of Fatty Liver Disease and Cancer$1,245,289
ZIA · FY2021 · AA · contact PI
Molecular mechanisms of liver injury, repair, and immunity$1,245,289
ZIA · FY2021 · AA · contact PI
S-adenosylmethionine treatment in alcoholic cirrhosis$353,008
U01 · FY2021 · AA
Molecular mechanisms of liver injury, repair, and immunity$1,286,596
ZIA · FY2020 · AA · contact PI
Pathogenesis and Novel Therapeutic Targets of Fatty Liver Disease and Cancer$1,286,596
ZIA · FY2020 · AA · contact PI
S-adenosylmethionine treatment in alcoholic cirrhosis$365,634
U01 · FY2020 · AA
Molecular mechanisms of liver injury, repair, and immunity$1,116,232
ZIA · FY2019 · AA · contact PI
Pathogenesis and Novel Therapeutic Targets of Fatty Liver Disease and Cancer$1,116,232
ZIA · FY2019 · AA · contact PI
S-adenosylmethionine treatment in alcoholic cirrhosis$380,663
U01 · FY2019 · AA
Immunologic Mechanisms of Alcoholic Liver Disease$1,231,160
ZIA · FY2018 · AA · contact PI
Innate immunity and cytokines in liver diseases$1,020,610
ZIA · FY2018 · AA · contact PI
Immunologic Mechanisms of Alcoholic Liver Disease$1,356,449
ZIA · FY2017 · AA · contact PI
Innate immunity and cytokines in liver diseases$963,239
ZIA · FY2017 · AA · contact PI
Immunologic Mechanisms of Alcoholic Liver Disease$1,464,927
ZIA · FY2016 · AA · contact PI
Innate immunity and cytokines in liver diseases$563,292
ZIA · FY2016 · AA · contact PI
Immunologic Mechanisms of Alcoholic Liver Disease$1,014,707
ZIA · FY2015 · AA · contact PI
Innate immunity and cytokines in liver diseases$1,014,707
ZIA · FY2015 · AA · contact PI
Immunologic Mechanisms of Alcoholic Liver Disease$1,201,402
ZIA · FY2014 · AA · contact PI
Innate immunity and cytokines in liver diseases$1,201,402
ZIA · FY2014 · AA · contact PI
Innate immunity and cytokines in liver diseases$1,278,180
ZIA · FY2013 · AA · contact PI
Immunologic Mechanisms of Alcoholic Liver Disease$888,227
ZIA · FY2013 · AA · contact PI
Immunologic Mechanisms of Alcoholic Liver Disease$1,301,353
ZIA · FY2012 · AA · contact PI
Innate immunity and cytokines in liver diseases$1,100,053
ZIA · FY2012 · AA · contact PI
Innate immunity and cytokines in liver diseases$1,096,687
ZIA · FY2011 · AA · contact PI
Immunologic Mechanisms of Alcoholic Liver Disease$1,033,768
ZIA · FY2011 · AA · contact PI
Mechanisms of Alcoholic Liver Disease$1,202,007
ZIA · FY2010 · AA · contact PI
Innate immunity and cytokines in liver disease$822,841
ZIA · FY2010 · AA · contact PI
Innate immunity and cytokines in liver disease$728,387
ZIA · FY2009 · AA · contact PI
Mechanisms of Alcoholic Liver Disease$649,597
ZIA · FY2009 · AA · contact PI
Mechanisms of Alcoholic Liver Disease$964,607
Z01 · FY2008 · AA · contact PI
Immunity, liver injury and repair$373,928
Z01 · FY2008 · AA · contact PI
Immunity, liver injury and repair$833,596
Z01 · FY2007 · AA · contact PI
Mechanisms of Alcoholic Liver Disease$600,071
Z01 · FY2007 · AA · contact PI
Immunity, liver injury and repair$0
Z01 · FY2006 · AA · contact PI
Mechanisms of Alcoholic Liver Disease$0
Z01 · FY2006 · AA · contact PI
Mechanisms of Alcoholic Liver Disease$0
Z01 · FY2005 · AA
Immunity, liver injury and repair$0
Z01 · FY2005 · AA
Mechanisms of Alcoholic Liver Disease: Dis-regulation of$0
Z01 · FY2004 · AA
Biological Significance and Therapeutic Potential of Cyt$0
Z01 · FY2004 · AA
Biological Significance and Therapeutic Potential of Cyt$0
Z01 · FY2003 · AA
Mechanisms of Alcoholic Liver Disease: Dis-regulation of$0
Z01 · FY2003 · AA
Molecular Mechanism For Resistance To Interferon Therapy$0
Z01 · FY2002 · AA
Cytokines in Alcoholic And Nonalcoholic Fatty Liver$0
Z01 · FY2002 · AA
Cytokines In Liver Disease$0
Z01 · FY2002 · AA
Synergistic Effect Of Alcohol And Viral Hepatitis On Liv$0
Z01 · FY2002 · AA
Molecular Mechanism For The Antiviral And Antitumor Acti$0
Z01 · FY2002 · AA
Molecular Mechanism For Activity of Interferon$0
Z01 · FY2001 · AA
Effect Of Alcohol And Viral Hepatitis On Liver Injury$0
Z01 · FY2001 · AA
Molecular Mechanism For Resistance To Interferon Therapy$0
Z01 · FY2001 · AA
TISSUE SPECIFIC CNTRL ALPHA 1B ANDRENOCEPTOR EXPRESSION$99,010
R29 · FY2000 · CA